Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature review
Introduction: Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad antifungal cover and favorable side effect profile but, notably, it has no activity...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | IDCases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250918300064 |